![]() Siegfried Siegfried Holding is a company that develops and manufactures drug substances and products. | ![]() Ergomed Ergomed Group is a company that provides drug development services to the pharmaceutical industry. | Remington Davis Remington Davis is a research institute offering clinical research, and patient care services. | |||
Founding Date | Founding Date 2005 | Founding Date 1873 | Founding Date 1997 | Founding Date 1992 | Founding Date 1923 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Hyderabad, IN HQ Hamburg, DE Turkapally, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN see more | Locations Zofingen, CH HQ Nantong, CN Saint Vulbas, FR Hameln, DE Minden, DE Birżebbuġa, MT Barberà Del Vallès, ES see more | Locations Guildford, GB HQ | Locations Columbus, US HQ | Locations Salzgitter, DE HQ |
Employees | Employees 5,75359% increase | Employees 3,886 | Employees 1,800 | Employees 21 | Employees 422% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) ₹55.1b (FY, 2025) | Revenue (est.) CHF1.3b (FY, 2025) | Revenue (est.) £145.3m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ₹25.4b (FY, 2025) | Cost of goods CHF879.1m (FY, 2025) | Cost of goods £86.1m (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ₹30.1b (FY, 2025) | Gross profit CHF463.5m (FY, 2025) | Gross profit £60.3m (FY, 2022) | Gross profit N/A | Gross profit N/A |
Net income | Net income ₹3.5b (FY, 2025) | Net income CHF168.4m (FY, 2025) | Net income £15m (FY, 2022) | Net income N/A | Net income N/A |

Siegfried Holding is a company that develops and manufactures drug substances and products.
View company
Ergomed Group is a company that provides drug development services to the pharmaceutical industry.
View companyRemington Davis is a research institute offering clinical research, and patient care services.
View companySchaper & Brummer is a manufacturer and distributor of pharmaceuticals.
View company